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A B S T R A C T
This study demonstrates the ability of an electrochemical sensor based on molecularly imprinted polymers
(MIPs) to selectively quantify 3,4-methylenedioxymethamphetamine (MDMA), also known as ecstasy, in bio-
logical samples. The device was constructed using ortho-phenylenediamine (o-PD) as the MIP’s building
monomer at the surface of a screen-printed carbon electrode (SPCE). The step-by-step construction of the SPCE-
MIP sensor was characterized by cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS).
Density functional theory (DFT) calculations and modelling were performed not only to understand template-
monomer interaction but also to comprehend which possible polymer structure - linear or ramified poly(o-PD) –
indeed interacts with the analyte. The prepared sensor worked by directly measuring the MDMA oxidation signal
through square-wave voltammetry (SWV) after an incubation period of 10min. Several parameters were opti-
mized, such as the monomer/template ratio, the number of electropolymerization scanning cycles, and the
incubation period, to obtain the best sensing efficiency. Optimized sensors exhibited suitable selectivity, re-
peatability (2.6%), reproducibility (7.7%) and up to one month of stable response. A linear range up to
0.2mmol L−1 was found with an r2 of 0.9990 and a limit of detection (LOD) and quantification (LOQ) of 0.79
and 2.6 μmol L−1 (0.15 and 0.51 μgmL−1), respectively. The proposed sensor was successfully applied to human
blood serum and urine samples, showing its potential for application in medicine and in forensic sciences.
1. Introduction
Ecstasy is a term coined by a Californian drug-dealer to boost his
sales of 3,4-methylenedioxymethamphetamine (MDMA) in the early
1980s [1]. It was at that decade when this compound started to be sold
as street-drug that could generate novel sensations that are not easily
describable: “MDMA represents a novel class of compounds, which are
characterized by a unique set of effects that are neither hallucinogenic
nor stimulant but a combination of both” [2,3]. However, its original
synthesis can be traced back to 1912, by a German chemist named
Anton Köllisch, who would probably continue to produce fine chemical
work had not he died young in the midst of the first world war [1]. Up
to the moment, there seems not to be any recognized medical appli-
cation of MDMA, but many voices continue to advocate a greater in-
vestment in its research as a therapeutic agent [4]. However, its det-
rimental health effects (which include enhancing mental disorders like
depression and anxiety, promoting panic attacks, creating adverse
health effects like seizures, arrhythmia, or hyperthermia, producing
permanent damage in brain function, liver, kidney and heart toxicity;
and even causing death [5–9]), along with an increase in its recrea-
tional consumption by some groups [10], generate fear around its
handling, even if to the best intended purposes.
The metabolism of MDMA is mainly mediated by hepatic CYP450
enzymes, originating 3,4-methylenedioxyamphetamine (MDA) by N-
demethylation. Both MDMA and MDA are then O-demethylenated to
the catecholic compounds N-methyl-α-methyldopamine (N-Me-α-
MeDA) and α-methyldopamine (α-MeDA), respectively, which can
undergo oxidation to the correspondent redox-active ortho-quinones.
These ortho-quinones may be conjugated with reduced glutathione
(GSH), originating glutathionyl adducts. The systemic formation of 5-
(glutathion-S-yl)-N-methyl-α-methyldopamine [5-(GSH)-N-Me-α-
MeDA] and 5-(glutathion-S-yl)-α-methyldopamine [5-(GSH)-α-MeDA]
may be followed to further metabolism into N-acetyl-cysteine (NAC)
conjugates [11]. From these compounds, MDA, N-Me-α-MeDA and α-
MeDA can be also present, however MDMA levels in plasma and urine
are normally higher than these compounds. Not surprisingly, since the
quantification of this drug in biological fluids in an easy and accurate
way would be of obvious great interest for health and forensics sci-
ences, there is a large number of publications concerning the analytical
determination of MDMA, in a wide variety of matrices – both biological
fluids and tissues (such as plasma, urine, saliva, sweat, and hair), as
well as the source materials (tablets, salts, and crystals) [2,12,13] –
making use of a wide variety methods. Capillary electrophoresis (CE)
with diode array detection (DAD) [14], gas chromatography (GC) with
detection by flame ionization detection (FID) [15] or by mass spec-
trometry (MS) [16], liquid chromatography (LC) with detection by
spectrophotometry [17], fluorescence [18] or MS [19], and even direct
MS [20], among others [2,12,13,21–24] have been used to determine
MDMA. One can also find scarce electroanalytical methodologies in
literature, (more about these methods will be debated in the section
Results and discussion) [25–28].
Considering the huge relevance of sample preparation in analytical
chemistry [29], research efforts have also been dedicated to this matter
including the use of classical techniques like liquid-liquid extraction
(applied in the analysis of oral fluid by ion mobility spectrometry and
infrared spectroscopy [22]) or supported liquid extraction (applied in
the analysis of ecstasy tablets by GC–MS [30]) and less classical tech-
niques like suspended droplet microextraction (applied in the analysis
of human hair by LC-UV [17]). Molecularly imprinted polymers (MIPs)
are ‘chemical tissues’ with selective recognition lacunas for analytes,
somehow imitating antibodies [31–34]. These chemical fabrics are
obtained by polymerization, a process in which the building blocks
(monomers) are entangled around a target template (normally, the
aimed analyte). Following polymerization, the template molecule is
removed, and the MIP is manufactured, it now possesses spots com-
plementary in shape, size, and functionality to the imprinted molecule.
Electrochemical MIPs are a special kind of MIPs, which synergistically
combine the MIPs’ advantages (in particular their selectivity) with the
inherent gains of electrochemical sensors, like simplicity, sensitivity,
portability, speed of analysis and user-friendliness, these are important
key features in forensics [35–37]. Electropolymerization has been the
correct choice especially in the preparation of MIPs with electro-
analytical sensing, it enables a simple way of controlling the polymers
thickness and morphology, it is reproducible and permits polymeriza-
tion in an aqueous media [38–41].
In the present study, a novel electrochemical sensor for MDMA was
constructed based on the electrochemical polymerization of o-pheny-
lenediamine (o-PD), in the presence of the analyte MDMA, thus forming
a MIP, on the surface of a portable screen-printed carbon electrode
(SPCE). Subsequently to optimization and analytical validation, it was
applied in the analysis of biological samples, namely human blood
serum and urine. Although one can find in literature a few manuscripts
developing MIPs for MDMA [42–44] (MIPs were developed by ther-
mopolymerization, using methacrylic acid, ethyleneglycoldimethacry-
late and 2,2’-azobis(isobutyronitrile) as the building monomer, cross-
linker and radical initiator, respectively), to the best of the authors’
knowledge, none was developed by electropolymerization.
2. Experimental
2.1. Chemicals
All commercial reagents were of analytical grade and were used
without further purification. All aqueous solutions were prepared using
ultrapure water with resistivity not less than 18.2MΩ cm at 298 K.
Potassium hexacyanoferrate (III), potassium hexacyanoferrate (II) tri-
hydrate, o-PD, methamphetamine, epinephrine, dopamine, caffeine and
tyramine were purchased from Sigma-Aldrich, noradrenaline was pur-
chased from Fluka and amphetamine from Tocris Bioscience. Acetate
buffer 0.1mol L−1, pH 5.0 was prepared with sodium acetate and acetic
acid both purchased from Sigma-Aldrich.
2.2. Equipment
Voltammetric measurements, such as cyclic voltammetry (CV) and
square wave voltammetry (SWV), were carried out using an Autolab
PGSTAT10 potentiostat/galvanostat controlled by GPES software.
Electrochemical impedance spectroscopy (EIS) studies were performed
using an Autolab PGSTAT204 potentiostat/galvanostat expanded with
a FRA32M EIS module (Metrohm) and the NOVA 1.10.1.9 software for
data acquisition. Screen-printed carbon electrodes (SPCE, Metrohm, ref.
110) with carbon working (d=4.0mm) and auxiliary electrodes and a
silver (Ag) pseudo-reference electrode were used.
Magnetic resonance spectroscopy (NMR) spectra were recorded
with a Bruker Avance 300 spectrometer (300.13MHz for 1H and
75.47MHz for 13C). Chemical shifts (δ) are reported in ppm and cou-
pling constants (J) in Hz; the internal standard was TMS.
Positive-ion Electrospray ionization (ESI) mass spectra were ac-
quired with a QTOF 2 instrument. Nitrogen was used as nebuliser gas
and argon as collision gas; the needle voltage was set at 3000 V, with
the ion source at 80 °C and the desolvation temperature at 150 °C; the
cone voltage was 35 V.
2.3. MDMA purification and characterization
MDMA (hydrochloride salt) was extracted and purified from high
purity MDMA tablets kindly provided by the Portuguese Criminal Police
Department. Briefly, tablets were crushed in a porcelain mortar, dis-
solved in 10% hydrochloric acid and filtered through G4. The filtered
solution was neutralized with 20% sodium hydroxide and extracted 3
times with dichloromethane. The organic phase was then washed three
times with water and dehydrated with anhydrous sodium sulfate.
Dichloromethane was evaporated in a rotary evaporator to yield an oil,
which was dissolved in methanol. The methanol solution was acidified
with 37% hydrochloric acid and MDMA hydrochloride crystals were
obtained by stepwise addition of ethyl ether, following by storage at
4 °C overnight. At the end, crystals were filtered and washed with cold
ethyl ether. The obtained salt was pure and fully characterized by NMR
and mass spectrometry (MS) methodologies (NMR and MS spectra are
shown in the Supporting information). Obtained results are in ac-
cordance with literature [19,45–48].
2.4. Preparation of the SPCE-MIP
Prior to modification, the bare SPCE were rinsed with water and
dried under a N2 flow. The MIP-sensor was obtained by electro-
polymerization of a solution containing 0.5mmol L−1 of the monomer
o-PD and 2.0mmol L−1 of the template and target molecule MDMA, in
acetate buffer pH 5.0. A 20 μL drop of this solution was released at the
surface of the SPCE and then the electropolymerization was achieved,
in this solution, by applying 5 CV scans in the potential range between
−0.0 V and +1.2 V, at a scan rate of 100mV s−1. The non-imprinted
polymer (NIP) sensor was prepared using the same polymerization
conditions without the template molecule. After electropolymerization,
electrodes were washed with deionized water and subjected to template
extraction by submersion in a methanol/deionized water (50:50, v/v)
solution, under stirring, for 10min. Electrodes were finally washed with
deionized water and dried using a N2 flow.
2.5. Theoretical studies
The following commercial software were used in the theoretical
studies: Spartan'16 from Wavefunction and Gaussian09 package [49]
from Gaussian. Spartan’s systematic conformational analysis algorithm,
mixing Monte Carlo and Molecular Dynamics simulations for the sam-
pling of conformers with energies in accordance with the Boltzmann
energy distribution at room temperature[83]. Merck Molecular Force
Field (MMFF) was the force field used.
Subsequent geometry optimizations on the most stable conforma-
tions, considered good candidates to model the MIP and its interaction
with the MDMA substrate, were performed with Gaussian09 using first
the Hartree-Fock method with the 6-31G(p) basis set [50,51]. Fol-
lowing, B3LYP-D3 dispersion-corrected functional was used, based on
Density Functional Theory (DFT) [52–54] with the 6-31G(d,p) basis set.
Finally, the final geometries for the best candidates were evaluated as
true minimum performing frequency calculations, accepting only op-
timized geometries with all positive eigenvalues in the Hessian matrix.
2.6. Electrochemical measurements
Electrochemical measurements were performed by SWV after in-
cubation of the SPCE-MIP directly on 50 μL of MDMA solutions with
different concentrations for 10min, (non-labelled measurements, i.e. no
redox probes were used), supporting electrolyte was acetate buffer,
0.1 mol L−1. SWV was performed in the potential range of 0.0 to
+1.6 V, at a frequency of 25 Hz, with the pulse amplitude of 19.95mV
and step potential of 5.1mV.
Additionally, the step-by-step construction of the modified elec-
trodes was characterized by CV and EIS. CV measurements were per-
formed between −0.5 and 1.0 V at a scan rate of 50mV s−1 using a
2.0 mmol L−1 of [Fe(CN)6)]3−/4− with 0.1mol L−1 KCl in acetate
buffer solution pH 5 as redox probe. EIS experiments were conducted
using the same probe, a single sine wave type with amplitude of 0.01 V
and applied potential of 0.16 V, in a frequency range from 0.1 Hz to
100 kHz.
All measurements were performed at room temperature (ca. 25 °C).
2.7. Biological samples
Drug-free blood plasma and urine samples were collected from a
healthy adult. Both biological samples were spiked with different
amounts of the stock solution of MDMA and the standard addition
method was used for the quantification of MDMA.
3. Results and discussion
3.1. Sensor development and characterization
The overall development process of the SPCE-MIP sensor is depicted
in Fig. 1. During each step of the construction, the SPCE-MIP sensor was
characterized by CV and EIS (Fig. 2) using 2.0mmol L−1 [Fe(CN)6)]3−/4−
and 0.1 KCl solution. The CV characterization showed that the bare SPCE
allow charge transfer with the typical pair of diffusional reversible peaks
in CV [55,56]. When the MIP is formed on the electrode surface, the
current decreases in CV and the charge transfer resistance (Rct) in EIS
clearly increases (the semicircle diameter of Nyquist Plot increased from
43.8Ω to 179.3 KΩ), thus both the SPCE-MIP before the removal of the
template, and the SPCE-NIP (167.3 KΩ) work as insulators. It is re-
markably noticeable the difference between the SPCE-MIP before and
after removing the template (308.0Ω), where the MDMA molecules left
the cavities and the redox probe obtained easier access to the electrode
surface [57], this being partially reverted when incubating with MDMA
(364.1Ω). The removal of the template can also be visualized by SWV
(Fig. S1 shown in the Supporting information), since there is not any peak
after the template extraction.
Several information can be obtained from the CVs of the electro-
polymerization process (Fig. S2 shown in the Supporting information)
[57,58]. Firstly, the lack of any peak is the reverse scan shows that the
process is irreversible. Then, the current decreases substantially with
each cycle showing that the process is quite efficient. The current
quickly tends to zero showing that the newly formed poly(o-PD) is
covering the electrode´s surface with a non-conductive film [58]. Sev-
eral parameters in the preparation of the SPCE-MIP sensor were opti-
mized, namely: monomer concentration, template concentration and
number of cycles in the electropolymerization as well as the time of
incubation with the analyte prior to analysis (Fig. 2). As showed in
Fig. 3A and B, the best analytical signal was found with 0.50mmol L−1
o-PD and 2.0 mmol L−1 MDMA, which means a monomer:template
ratio of 1:4. The amount of polymer in the electrode surface greatly
influences the obtained signal, an excessively thick MIP layer exhibits
low binding capacity, poor site accessibility, and slow absorption ki-
netics. The MIP thickness can be adjusted by controlling the number of
cycles of electropolymerization [59], the optimal sensitivity to MDMA
was obtained with 5 scanning cycles (Fig. 3C). Fig. 3D shows the evo-
lution of peak current with incubation time at the given conditions,
10min was found to be the optimal analyte-MIP interacting time.
3.2. Theoretical studies
The preparation of electro-polymerized MIPs with o-PD has been
applied in a variety of analytes ranging from human cardiac troponin T
[60], paracetamol (also known as acetaminophen) [61], dopamine [62]
to perfluorooctane sulfonate [58]. The produced films are rather ad-
vantageous since they can be thin, stable and can be created in-situ on
several types of substrates [58]. o-PD is one of the most common
monomers used in electropolymerization, it has good chemical stability
and the easy polymerization creates a non-conducting compact (rigid)
film with hydrophilic and hydrophobic recognition sites. Although o-PD
can easily react using both amine groups simultaneously [63–67] and it
is possible to obtain a fully ‘linear’ polymer [68], however that occurs at
very low potentials [69]. Apparently, with this electropolymerization a
polymer structure with free amine groups is obtained, which strongly
facilitates monomer-analyte interaction [66].
In order to further our investigation of the interaction between the
o-PD monomers and the MDMA substrate, computational studies of the
interaction between two types of o-PD tetramers and the MDMA
Fig. 1. Schematic illustration of the construction of the MIP-
SPCE sensor.
substrate to find the strongest interaction were carried out, which
would be a strong indication of the kind of polymer synthesized and
responsible for the detector’s selectivity. Two isomers, representative of
the o-PD polymers were chosen (Fig. 4); their essential difference is
their “closed” or “open” character – depending on whether both
terminal nitrogens of the monomers bond to the ring carbon on the next
monomer during polymerization, or only one of them. This basic dif-
ference affects not only their stability – preserving monomer
Fig. 2. A) characterization of the step by step
construction of the sensor, measurements per-
formed over a 2.0mmol L−1 [Fe(CN)6)]3-/4-: A
- CV measurements and B - EIS Nyquist dia-
grams with suitable fitting (the circuit used is
shown within the figure). 1) bare SPCE; 2)
SPCE-MIP after polymerization; 3) SPCE-MIP
after template extraction; 4) SPCE-MIP after
incubation; 5) SPCE-NIP.
Fig. 3. A) Optimization studies, peak current obtained by SWV of an MDMA solution, 0.1 mmol L−1, at pH=5.0: A1) with different o-PD concentration (poly-
merization conditions: 20 cycles, 2.0 mmol L−1 MDMA and 10min of incubation); B) with different MDMA (template) concentration (polymerization conditions: 20
cycles, 0.50mmol L−1 o-PD and 10min of incubation); C) with different number of cycles of polymerization (polymerization conditions: 0.50mmol L−1 o-PD,
2.0mmol L−1 MDMA and 10min of incubation); D) with different incubation time (polymerization conditions: 0.50mmol L−1 o-PD, 2.0mmol L−1 MDMA and 20
cycles), the CVs had their baseline corrected by the ‘moving average’ feature present in the GPES software.
aromaticity in the first case but not in the second – but also their tor-
sional abilities and the availability of terminal nitrogens able to non-
covalently interact with the substrate, and thus contribute to the “lock
and key” selectivity to MDMA.
Our computational study consisted of, initially, the systematic
prospection of the potential energy surface of the many possible con-
figurations of non-covalently interacting pairs specified below, o-PD
tetramer 1 and MDMA and tetramer 2 and MDMA, and then geometry
optimizations of the most stable conformers with Quantum Mechanical
methods, in order to find the most favourable interaction in each case.
The computational strategy used would be described as a “ladder” of
successive calculation methods, approximating more precisely at each
level the correct quantum-mechanical description of the total and in-
teraction energy of the studied compounds. Such use of successive ap-
proximations is a standard computational protocol necessary to keep
the vast number of calculations necessary for a systematic study of the
wide range of possible conformers at feasible computational cost. As
stated earlier, for initial conformer search and geometry optimizations,
Spartan’s systematic conformational analysis algorithm, mixing Monte
Carlo and Molecular Dynamics was used, and in both cases, ten thou-
sand conformers were searched; all with energies low enough to exist at
a room-temperature Boltzmann distribution were kept, resulting in
5000 and 1100 conformers for the tetramers 1 and 2, respectively.
All of them were then geometry-optimized using Spartan’s im-
plementation of the PM6 semi-empirical method [70]. The PM6 method
offers a more precise description than the pure molecular mechanics
description used in the first “rung” of our investigation, the systematic
conformer search employing the MMFF. In our second “rung”, the
geometry optimizations using PM6, we were able to investigate with
higher precision the relative energy of the thousands of acceptable
conformers, in order to select the most stable among them for further
investigations.
As previously exposed in less detail, the twenty most stable con-
formers for each case were then geometry-optimized using the
Gaussian09 package [49] with a yet more precise level of theory, a third
“rung” in our ladder, the Hartree-Fock method. For this third step, the
6-31G(p) basis set [50,51] was used, alongside the PCM continuum
model, for the simulation of the dielectric constant of the solvent used
in the synthesis environment, water. Subsequently, the 10 most stable
candidates for each case (the twenty conformers and respective en-
ergies are shown in Supporting information) were geometry-optimized
in Gaussian09 using the fourth and highest-precision “rung” in our
ladder: the B3LYP exchange-correlation functional with Grimme’s D3
correction for dispersion interactions [52–54], a bigger 6-31G(d,p)
basis set with polarization functions on hydrogen atoms to capture
hydrogen bonding [50,51], and again the PCM model for water. Finally,
bonding and reaction energy for the most stable configuration in each
case was calculated by geometry-optimizing the interacting molecules
separately with the same methods, of the last step, that is, of our fourth
“rung”, and subtracting their separate energies from the total energy of
the interacting molecules. Two such calculations were performed. The
former involves the reaction energy for each tetramer formation. As the
tetramer formation involves the condensation of four o-PD monomers
with loss of six hydrogen molecules, both were optimized separately.
The later was the separate calculation of both tetramers 1 and 2 in their
final conformation in the interaction with the MDMA substrate.
For all the “fourth rung”, B3LYP-D3 calculations, the stability of the
molecule, that is, the potential energy surface (PES) minimum character
of the resulting geometry, was confirmed by frequency calculations –
that is, calculation of the Hessian matrix for the resulting forces in each
geometry.
We can see that the so-called ramified tetramer, which we named
tetramer 1, has the strongest interaction with the substrate (Fig. 4). The
1.25 kcal mol−1 difference in interaction energies is enough to strongly
indicate that the majority of the MDMA molecules is interacting with
the ramified tetramer, as indicated by previous literature [66]. How-
ever, the vast difference in formation energy for both tetramers heavily
favours the formation of the so-called linear tetramer, which we named
tetramer 2. This indicates that the tetramer 2 has a much larger po-
pulation.
We should highlight that a 1.25 kcal mol−1 difference, when un-
derstood from the standpoint of Boltzmann populations, which follow
an exponential trend, indicate a clear selectivity in the MDMA-MIP
interaction favoring the ramified tetramer. While no specific interac-
tions – e.g., strong hydrogen bonds – seem responsible for such a se-
lectivity, it stands out that the ramified tetramer is able to fold using the
MDMA molecule as a template. We are led to ascribe the MDMA-MIP
stability to a sum total of non-covalent weak interactions able to shape
the MDMA-MIP complex (see Fig. 4). The linear tetramer is less able to
provide such a stabilization, as we note from the optimized geometries
in Fig. 4. However, it is clearly influenced by the presence of the MDMA
molecule, which breaks the tetramer’s linearity even if that means ap-
parently straining it, and despite its aromaticity. In other words, the
interaction of the MDMA with the linear tetramer is also strong, to the
point of compensating a disturbance of the latter’s aromatic stabiliza-
tion. This brings us to a second point of relevance in our results: the
intrinsic stability of the linear tetramer, which is much larger than that
of the ramified one, suggests that it is present in a much larger popu-
lation. If we take into account that its interaction with MDMA is also
strong, even if not the most favorable between the two isomers, we are
pushed to consider that the linear tetramer also plays an important role
in the electrode's detection ability. Most significantly, however, is the
Fig. 4. Chemical structures of MDMA, ramified and linear tetramers of o-PD (tetramer 1 and 2, respectively). Relative energies and model for the most stable MDMA-
tetramer conformer.
discrepancy between intrinsic stability of the tetramers and their ca-
pacity to bind MDMA, which follow separate trends. Such a discrepancy
could not be captured by an analysis of the interaction of monomers
alone with MDMA, which is the most used protocol in theoretical
modelling of MIPs. The interaction of monomers alone, which does not
worry to look at the intrinsic stability of the polymer, may leave the
greatest energetic contributions to the system out of the model, and be
the source of important misevaluations. This would be even more the
case in the present study, in which o-PD monomers are their own cross-
linkers, and the stability of the system as a whole is greatly influenced
by the intrinsic stability of the polymer chain.
Although this simple model is able to differentiate the interaction
energy between the MDMA and the two tetramers, it is not sufficient to
investigate the synthesis process, as it is not considering the transition
states, and the associated activation energy necessary to build a com-
plete energy profile of the reaction mechanism. As such, it cannot in-
form the rational design of one or another polymerization process, but
offers important insights into the relative weights of the intrinsic sta-
bility of the polymer and the strength of its interaction with the analyte.
It also throws further light into the nature of o-PD polymers, which had
so far been inconclusive from experimental studies.
Finally, a more complete model, involving the prospection of a
potential energy surface for the conformation of o-PD monomers
around MDMA and other tested substrates and the reaction mechanism
for the tetramer formation is under development, and will potentially
provide further insight into the process of MIP synthesis and selectivity.
3.3. Analytical performance and sample analysis
Under optimized conditions, the sensor was tested with different
concentrations of MDMA by SWV (Fig. 5). SWV was the electro-
analytical technique applied due to the better sensibility it often allows
[71–77]. The corresponding calibration curve (n= 11) had the fol-
lowing analytical parameters: r2 of 0.9990; peak current (μA)= (89.0
± 1.6)× 10−3 [MDMA] (μmol L−1)+ (61 ± 20)×10−3; limit of
detection (LOD) and quantification (LOQ) of 0.79 and 2.6 μmol L−1
(0.15 and 0.51mg L−1), respectively; linear range up to 200 μmol L−1
(0.39 g L−1). LOD and LOQ were calculated as three and ten times the
standard deviation of the intercept/slope, respectively.
The selectivity of the developed MIP was studied in a comparison
with the endogenous molecules epinephrine, norepinephrine and do-
pamine as well as tyramine, amphetamine, methamphetamine and
caffeine, which are structurally similar to MDMA. The results are
summarized in Table 1 and the SWVs are shown as Fig. S3 in the
Supporting information. For each compound, the selectivity factor (α)
was calculated by dividing the MDMA peak current by the other com-
pound’s peak current. It can be observed that only tyramine and do-
pamine could potentially give a positive result out of the tested com-
pounds. However, tyramine oxidizes at a lower potential, thus being
eletroanalytically distinguishable, and, besides, in both cases their
concentration in body fluids is normally substantially lower than
MDMA’s [78,79], so in practice they are not expected to meaningfully
interfere.
The produced SPCE-MIP sensors were studied in terms of repeat-
ability, reproducibility and stability. Repeatability was obtained by
intra-day analysis of a MDMA solution using the same electrode, which
was subjected to the extraction step between each measurement.
Reproducibility was determined by inter-day measuring a MDMA so-
lution using newly obtained electrodes. The stability study was con-
ducted testing a MDMA solution using the same electrode over several
days. All studies were performed using a 100 μmol L−1 MDMA solution;
values 2.6% (n= 5), 7.7% (n=4) and a variation of less than 4.5%
along 28 days, were found to repeatability, reproducibility and stabi-
lity, respectively.
MDMA is an electroactive compound and one can find a few works
concerning its electroanalysis, specifically using a glassy carbon elec-
trode (GCE) [26], a GCE modified with cucurbit[6]uril [25], and screen
printed graphite electrodes [28]. Literature suggests that MDMA vol-
tammetric oxidation in solution, around +0.9 V at pH 7 [28], occurs at
the aromatic forming a cation radical that dimerizes [26]; radical di-
merization preceding further molecule oxidation or reduction is a
common way of annulling radicals [80]. The LODs in the corresponding
analysed matrices can be found in Table 2, however the selectivity of
this methodology, due to the presence of MIPs, is a clear advantage.
Fig. 5. The SWV curves of the sensor after 10min of incubation with 50 μL
MDMA solution at different concentrations: 2.5, 5, 7.5, 10, 15, 20, 25, 50, 75,
100 and 200 μmol L−1. SWV was performed in the potential range of 0.0 to
+1.6 V, at a frequency of 25 Hz. Polymerization conditions: 0.50mmol L−1 o-
PD, 2.0mmol L−1 MDMA and 5 scanning cycles. Inlay: the corresponding ca-
libration curve.
Table 1
Selectivity experiments, all compounds were analysed with a concentration of
100 μmol L−1.
compound structure peak current /μA α
MDMA 7.38 –
dopamine 1.31 5.6
epinephrine < LOD –
norepinephrine < LOD –
tyramine 2.64 2.8
amphetamine < LOD –
metamphetamine < LOD –
caffeine < LOD –
The proposed MIP-SPCE sensor was applied to the quantification of
MDMA in biological matrices, namely human blood serum and urine
samples (calibration curves are shown as Fig. S4 in the Supporting in-
formation). Recovery tests experiment was performed by spiking the
samples with MDMA, followed by dilution with acetate buffer solution
pH 5, a recovery of (81.0 ± 2.4) % was obtained with diluted urine
(1:10) and (91.4 ± 1.1) % with diluted serum (1:20). Samples were not
subjected to any additional pre-treatment steps. The calibration curves
(n=5) had the following analytical parameters: a) urine - r2 of 0.998,
peak current (μA)= (100.9 ± 2.7)×10−3 [MDMA] (μmol L−1
)+ (0.16 ± 0.17), LOD and LOQ of 6.4 and 21 μmol L−1 (1.2 and
4.1mg L−1), respectively, with a linear range of up to 100 μmol L−1
(0.19 g L−1); b) blood serum – r2 of 0.9997, peak current
(μA)= (42.37 ± 0.95)×10−3 [MDMA] (μmol L−1)− (73 ± 69)×
10−3, LOD and LOQ of 3.9 and 13 μmol L−1 (0.75 and 2.5mg L−1), re-
spectively, with a linear range of up to 100 μmol L−1 (0.19 g L−1). Both
LODs and LOQs were calculated as three and ten times the standard
deviation of the intercept/slope, respectively.
In fatalities associated with MDMA, levels between 0.6 and
4.3 mg L−1, in admission, and post-mortem levels between 0.5 and
28.4mg L−1 were found [81]. Another publication attributes death to
the toxic effects of MDMA alone with a range of 0.5–54mg L−1 (13
cases) [82].
4. Conclusions
In this work, it was successfully shown that it is possible to obtain a
selective electrochemical sensor for MDMA using a SCPE-MIP. A poly(o-
PD) film was generated at the surface of a SPCE by electro-
polymerization of the monomer o-PD as a MDMA recognition element.
To the best of our knowledge, electrochemical determination of MDMA
based on an electropolymerized selective sensor has not been reported
before. Experimental parameters that affected the performance of the
SPCE-MIP sensor were studied and optimized, confirming electro-
analytical properties such as linearity, selectivity (in comparison with
endogenous and non-endogenous compounds with similar chemical
structures), stability, repeatability and reproducibility. Furthermore,
the sensor was applied in the analysis of MDMA in biological samples,
namely human blood serum and urine.
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